Petros Grivas
MD, PhD
Professor, Division of Oncology
👥Biography 个人简介
Dr. Petros Grivas is a GU oncologist with subspecialty expertise in urothelial cancer who contributed to EV-302 and EV-201 trials of enfortumab vedotin. He has evaluated enfortumab vedotin as monotherapy in cisplatin-ineligible patients and as a combination with pembrolizumab in first-line settings. His translational research explores predictive biomarkers for Nectin-4-directed ADC response.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Petros Grivas 的研究动态
Follow Petros Grivas's research updates
留下邮箱，当我们发布与 Petros Grivas（University of Washington / Fred Hutchinson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment